HK1022273A1 - In ovo vaccination against newcastle disease. - Google Patents

In ovo vaccination against newcastle disease.

Info

Publication number
HK1022273A1
HK1022273A1 HK00101235A HK00101235A HK1022273A1 HK 1022273 A1 HK1022273 A1 HK 1022273A1 HK 00101235 A HK00101235 A HK 00101235A HK 00101235 A HK00101235 A HK 00101235A HK 1022273 A1 HK1022273 A1 HK 1022273A1
Authority
HK
Hong Kong
Prior art keywords
newcastle disease
vaccination against
ovo vaccination
against newcastle
ovo
Prior art date
Application number
HK00101235A
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of HK1022273A1 publication Critical patent/HK1022273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK00101235A 1996-12-17 2000-02-29 In ovo vaccination against newcastle disease. HK1022273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203572A EP0848956A1 (fr) 1996-12-17 1996-12-17 In ovo vaccination contre la maladie de Newcastle
PCT/EP1997/007066 WO1998026800A1 (fr) 1996-12-17 1997-12-16 Vaccination in ovo contre la maladie de newcastle

Publications (1)

Publication Number Publication Date
HK1022273A1 true HK1022273A1 (en) 2000-08-04

Family

ID=8224711

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101235A HK1022273A1 (en) 1996-12-17 2000-02-29 In ovo vaccination against newcastle disease.

Country Status (18)

Country Link
US (1) US6348197B1 (fr)
EP (2) EP0848956A1 (fr)
JP (1) JP2001506253A (fr)
KR (1) KR100540856B1 (fr)
CN (1) CN1146443C (fr)
AR (1) AR010794A1 (fr)
AT (1) ATE271883T1 (fr)
AU (1) AU5758798A (fr)
BR (1) BR9713582A (fr)
CA (1) CA2273074C (fr)
DE (1) DE69730040T2 (fr)
DK (1) DK0938335T3 (fr)
ES (1) ES2224294T3 (fr)
HK (1) HK1022273A1 (fr)
PT (1) PT938335E (fr)
TW (1) TW537896B (fr)
WO (1) WO1998026800A1 (fr)
ZA (1) ZA9711333B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074614B1 (fr) * 1999-07-27 2004-07-07 Akzo Nobel N.V. Virus de la maladie de Newcastle recombinant pour la vaccination in ovo
CA2312626A1 (fr) 1999-07-27 2001-01-27 Akzo Nobel N.V. Virus recombinant de la maladie de newcastle utilise pour vacciner les embryons
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
EP1300157B1 (fr) 2001-10-04 2005-10-26 Centrum voor Onderzoek in Diergeneeskunde en Agrochemie Souche atténuée mutante du virus de la maladie de newcastle susceptible d'être utilisée pour la vaccination in ovo et utilisation de cette souche
MXPA04012881A (es) * 2002-06-21 2005-07-05 Wellstat Biologics Corp Administracion de virus terapeuticos.
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
WO2004113518A1 (fr) * 2003-06-20 2004-12-29 Microbix Biosystems Inc. Perfectionnements dans la production de virus
CN101460192A (zh) * 2006-03-30 2009-06-17 恩布里克斯公司 家禽疫苗接种的方法和组合物
FR2921387B1 (fr) * 2007-09-26 2012-04-20 Sanofi Pasteur Procede de production du virus de la grippe
CN102559607B (zh) * 2012-01-04 2013-03-27 扬州大学 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ATE112490T1 (de) * 1988-07-18 1994-10-15 Duphar Int Res Lebende newcastle-krankheit-virus-vakzine.
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease

Also Published As

Publication number Publication date
AR010794A1 (es) 2000-07-12
DK0938335T3 (da) 2004-11-29
KR20000069501A (ko) 2000-11-25
ZA9711333B (en) 1999-06-17
EP0938335A1 (fr) 1999-09-01
DE69730040D1 (de) 2004-09-02
ES2224294T3 (es) 2005-03-01
KR100540856B1 (ko) 2006-01-12
BR9713582A (pt) 2000-04-04
CA2273074A1 (fr) 1998-06-25
WO1998026800A1 (fr) 1998-06-25
ATE271883T1 (de) 2004-08-15
DE69730040T2 (de) 2004-12-30
JP2001506253A (ja) 2001-05-15
TW537896B (en) 2003-06-21
US6348197B1 (en) 2002-02-19
PT938335E (pt) 2004-11-30
CA2273074C (fr) 2008-04-29
CN1146443C (zh) 2004-04-21
CN1240360A (zh) 2000-01-05
AU5758798A (en) 1998-07-15
EP0938335B1 (fr) 2004-07-28
EP0848956A1 (fr) 1998-06-24

Similar Documents

Publication Publication Date Title
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
PL332633A1 (en) Vaccines
DZ2049A1 (fr) Vaccination in ovo contre la coccidiose.
ZA964726B (en) In ovo vaccination against coccidiosis.
AU4063095A (en) Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease
EP0958373A4 (fr) Vaccins
ZA976815B (en) Vaccine composition.
CY2407B1 (en) Acellular pertussis vaccine with diphthriae- and tetanus-toxoids.
ZA973642B (en) DNA vaccine formulations.
HK1022273A1 (en) In ovo vaccination against newcastle disease.
GB9626864D0 (en) Vaccine
ZA971414B (en) Growth promotion in chickens.
GB9625968D0 (en) Vaccine
ZA964724B (en) In ovo vaccination against coccidiosis.
GB9608106D0 (en) Animal Vaccines
ZA973824B (en) Vaccines
ZA987303B (en) Vaccine.
GB9622797D0 (en) Vaccine components against streptococcal disease
GB9604595D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9606032D0 (en) Vaccines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091216